Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | F2 | P00734 | 4/20 | 0.55 |
| ▸ | F10 | P00742 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16624911 | 0.93 | F2 (0.55) | KMT2AMEN1NPC1L3MBTL1ATM | |
| SCHEMBL232194 | 0.91 | F2 (0.59) | KMT2AMEN1NPC1F2F10 | |
| SCHEMBL16624892 | 0.89 | L3MBTL1 (0.71) | KMT2AMEN1NPC1L3MBTL1ATM | |
| SCHEMBL7141857 | 0.86 | F2 (0.55) | KMT2AMEN1NPC1F2F10 | |
| SCHEMBL28642234 | 0.86 | F2 (0.55) | KMT2AMEN1NPC1F2F10 | |
| SCHEMBL16624902 | 0.85 | L3MBTL1 (0.53) | KMT2AMEN1NPC1L3MBTL1ATM | |
| SCHEMBL16617094 | 0.84 | L3MBTL1 (0.68) | KMT2AMEN1NPC1L3MBTL1ATM | |
| SCHEMBL4405154 | 0.84 | F2 (0.56) | KMT2AMEN1NPC1F2F10 | |
| SCHEMBL30040482 | 0.84 | F2 (0.56) | KMT2AMEN1NPC1F2F10 | |
| SCHEMBL9066674 | 0.83 | ATM (0.74) | KMT2AMEN1NPC1L3MBTL1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2864284-B1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO KGAA (DE) | 2017-07-05 | — | — | EP | disclosed |
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | KMT2A 2118/4885MEN1 556/4885NPC1 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.